Inhibikase Therapeutics Announces Participation in Upcoming Investor Conferences During November 2026
Inhibikase Therapeutics announced management participation in the Jefferies Global Healthcare Conference (Nov 16-19, London) and the 9th Annual Evercore Healthcare Conference (Nov 30-Dec 2, Coral Gables). CEO Mark Iwicki will join a Jefferies fireside chat on November 16, with one-on-one meetings at both conferences.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.